title: Ocular surface bacterial colonisation in sedated intensive care unit patients.
abstract: We investigated the time-dependent ocular surface bacterial colonisation of sedated patients hospitalised in an intensive care unit and aimed to evaluate whether proper topical antibiotic prophylaxis could prohibit corneal infection. The study lasted 12 months and included 134 patients undergoing sedation and mechanical respiratory support for various medical reasons. Patients hospitalised for less than seven days and those with pre-existing ocular surface pathology were excluded. All patients were examined on admission by inspecting the cornea for erosions. Followup examinations were performed each subsequent day. Cultures were also obtained from the conjunctival sac of both eyes on admission and every seventh day until the end of sedation. Standard laboratory techniques were used for isolation, identification and antibiotic susceptibility testing of bacteria. Antibiotic treatment for prophylaxis was administered accordingly. Analysis was carried out for 70 patients. Duration of sedation ranged from seven to 122 days. Fifty-four (77%) patients were colonised by at least one bacterial species other than normal flora within seven to 42 days. Multiple bacteria were isolated from 28 patients undergoing prolonged sedation. Prevalent isolates were Pseudomonas aeruginosa, Acinetobacter spp. and Staphylococcus epidermidis. Infectious keratitis was prohibited in all cases. Ocular surface of long-term sedated patients was found to be colonised by various bacterial species and their isolation was closely associated with the time period of hospitalisation. The results of this study suggest that the early identification of ocular surface bacteria colonisation and the administration of topical antibiotics for prophylaxis can prohibit corneal infection in these patients.
authors.affiliation: Department of Ophthalmology, Microbiology and Anesthesiology, Patras University Hospital, Rion, Patras, Greece.
authors.forename: E K
authors.initials: EK
authors.lastname: Mela
authors.forename: E G
authors.initials: EG
authors.lastname: Drimtzias
authors.forename: M K
authors.initials: MK
authors.lastname: Christofidou
authors.forename: K S
authors.initials: KS
authors.lastname: Filos
authors.forename: E D
authors.initials: ED
authors.lastname: Anastassiou
authors.forename: S P
authors.initials: SP
authors.lastname: Gartaganis
mesh_terms: D000328:Adult; D000368:Aged; D019072:Antibiotic Prophylaxis; D001419:Bacteria / Q000187:drug effects / Q000254:growth & development*; D016292:Procedural Sedation; D003316:Corneal Diseases / Q000382:microbiology / Q000517:prevention & control; D024901:Drug Resistance, Multiple, Bacterial; D005123:Eye / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000382:microbiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D007634:Keratitis / Q000473:pathology; D007902:Length of Stay; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011446:Prospective Studies; D012121:Respiration, Artificial; D013997:Time Factors; D055815:Young Adult